Sexual dysfunction in patients with MDD treated with SSRIs - causes, measurement and prevention
Major Depressive Disorder(MDD) is serious psychiatric condition and they affect one in five people during their lifetime, the annual prevalence rates for the US population are 7.1% among adults, slightly more common among women (8.7%) than men (5.3%). Selective serotonin reuptake inhibitors are amo...
Main Authors: | Adrian Giermasinski, Magdalena Próchnicka, Dominika Nowak, Paweł Oszczędłowski, Justyna Nowaczek |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2021-09-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/JEHS/article/view/35357 |
Similar Items
-
Post-SSRI sexual dysfunction and SSRI induced sexual dysfunction - literature review
by: Eliasz Panek, et al.
Published: (2023-04-01) -
Does prenatal exposure to antidepressants cause autism? - literature review
by: Zuzanna Marczyńska, et al.
Published: (2024-02-01) -
A multicenter, randomized controlled study on the efficacy of agomelatine in ameliorating anhedonia, reduced motivation, and circadian rhythm disruptions in patients with major depressive disorder (MDD)
by: Ping Guo, et al.
Published: (2023-11-01) -
TED—Trazodone Efficacy in Depression: A Naturalistic Study on the Efficacy of Trazodone in an Extended-Release Formulation Compared to SSRIs in Patients with a Depressive Episode—Preliminary Report
by: Marcin Siwek, et al.
Published: (2023-01-01) -
A comparative study of personality aspects of females with depression using the antidepressant medications: selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs)
by: Saeed Pournaghash tehrani, et al.
Published: (2018-03-01)